Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
ImmVira's New-Generation Vector Poised to Enable CAR-T Treatment for Solid Tumors 2022-01-25 08:30
IMPRESSION Randomized Trial: Past the halfway mark and progressing rapidly 2022-01-24 23:35
Kintor Pharma Announced Successful Dosing of the First Patient for Acne Vulgaris Phase II Clinical Trial of KX-826 2022-01-24 21:47
MGI's New MGISP-Smart 8 Automated Sample Preparation System Makes International Debut at MEDLAB Middle East 2022-01-24 19:30
MGI's New MGISP-Smart 8 Automated Sample Preparation System Makes International Debut at MEDLAB Middle East 2022-01-24 19:30
Samsung Biologics Reports Fourth Quarter & Fiscal Year 2021 Financial Results 2022-01-24 16:25
Harbour BioMed Announces Dosing of First Patient in Combination Therapy Phase Ib/IIa Trial of Next-Generation Anti-CTLA-4 Antibody 2022-01-24 15:39
Innovent Announces the Approval of Pemazyre® (pemigatinib) in Hong Kong Market for the Treatment of Adults With Locally Advanced Or Metastatic Cholangiocarcinoma With A FGFR2 Fusion Or Rearrangement That Have Progressed After At Least One Prior Line Of Systemic Therapy 2022-01-24 15:22
Applied Pharmaceutical Science Inc. Announces FDA Approval of Investigational New Drug Application for APS03118, a Next generation RET Original New Drug for Unlimited Cancers 2022-01-24 13:10
New York Medical Group Publishes Research on Tech Neck 2022-01-24 12:39
Ascletis Announces First Patient Dosed in the Phase III Clinical Trial of FASN Inhibitor ASC40 Combined with Bevacizumab for Treatment of Recurrent Glioblastoma 2022-01-23 18:35
Innovent and Eli Lilly and Company Announced Final Clinical Results and Biomarker Analysis of Phase Ib Study of TYVYT® (Sintilimab Injection) Plus Bevacizumab Biosimilar Injection for Advanced Hepatocellular Carcinoma at ASCO GI Annual Meeting 2022 2022-01-22 08:00
Swiss Pharma Company - IDEOGEN takes over Special Access Program for BELEODAQ® (belinostat) 2022-01-22 04:24
ELEVAI LABS, INC. ANNOUNCES GLOBAL DISTRIBUTION PARTNERSHIP WITH PREMIER AESTHETIC DEVICE COMPANY DERMAPENWORLD 2022-01-21 13:41
Sihuan Pharmaceutical (0460.HK): Establishment of Joint Venture with Bluepha Co., Ltd. 2022-01-21 11:12
Hinova Announces First Patient Dosed in a Phase I Clinical Trial of HP518, an orally bioavailable Chimeric Degrader targeting Androgen Receptor for Prostate Cancer Treatment 2022-01-21 05:30
Suvoda Exceeds 2021 Targets; Poised for Continued Growth Supporting Complex Clinical Trials in 2022 2022-01-20 23:05
HanAll Biopharma Reports Full-Year 2021 Results and Provides Business Update 2022-01-20 22:00
Volition presents study data at ASCO GI 2022 on circulating nucleosomes for the detection of colorectal cancer and high-risk advanced adenomas 2022-01-20 21:30
Bridget Johnson Joins CSafe Global as Senior Vice President of Marketing 2022-01-20 21:15
1 293 294 295 296 297 895